ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 3g, Total Approximate Volume 1...

FDA Recall #D-0877-2017 — Class II — May 18, 2017

Recall #D-0877-2017 Date: May 18, 2017 Classification: Class II Status: Terminated

Product Description

ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 3g, Total Approximate Volume 115 mL, Single Dose Container bag, Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0524-32

Reason for Recall

Lack of assurance of sterility: Product bags leaking at seam.

Recalling Firm

SCA Pharmaceuticals — Little Rock, AR

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

70 bags

Distribution

Nationwide in the USA

Code Information

LOT # 20170508@15, Use By: 06/22/17

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated